United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
608.49
+7.17 (1.19%)
Nov 4, 2026, 4:00 PM EST - Market closed
United Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $710 → $695 | Buy | Reiterates | $710 → $695 | +14.22% | Oct 28, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $700 → $850 | Buy | Maintains | $700 → $850 | +39.69% | Oct 26, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $708 → $697 | Buy | Reiterates | $708 → $697 | +14.55% | Oct 22, 2026 |
| Raymond James | Raymond James | Buy Maintains $685 → $717 | Buy | Maintains | $685 → $717 | +17.83% | Oct 20, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $685 → $725 | Buy | Reiterates | $685 → $725 | +19.15% | Oct 19, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $700 | Buy | Maintains | $700 | +15.04% | Oct 16, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $321 → $368 | Sell | Maintains | $321 → $368 | -39.52% | Oct 15, 2026 |
| UBS | UBS | Buy Maintains $725 | Buy | Maintains | $725 | +19.15% | Oct 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.